美国 · SEC FORM 4
VOLITIONRX LTD
VNRX · NYSE · CIK 0000093314 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
2 同一窗口内观察到的 Form 4 交易行
0 sales · 2 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-17 · Reynolds Cameron John.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,196,849
- 上期报告
- 1,004,963
- 日均成交量
- 4,427,440
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | Reynolds Cameron John | 买入 (P) | Common Stock | 20,000 | USD 0.35 | USD 7,000 | SEC 申报 ↗ |
| 2025-10-14 | STILL TIMOTHY I | 买入 (P) | Common Stock | 48,076 | USD 0.51 | USD 24,519 | SEC 申报 ↗ |
| 2025-10-14 | Reynolds Cameron John | 买入 (P) | Common Stock | 110,000 | USD 0.51 | USD 56,100 | SEC 申报 ↗ |
| 2025-10-14 | Innes Guy Archibald | 买入 (P) | Common Stock | 96,153 | USD 0.51 | USD 49,038 | SEC 申报 ↗ |
| 2025-09-12 | Reynolds Cameron John | 买入 (P) | Common Stock | 15,000 | USD 0.66 | USD 9,900 | SEC 申报 ↗ |
| 2025-08-05 | Reynolds Cameron John | 买入 (P) | Common Stock | 78,125 | USD 0.64 | USD 50,000 | SEC 申报 ↗ |
| 2025-08-05 | Innes Guy Archibald | 买入 (P) | Common Stock | 78,125 | USD 0.64 | USD 50,000 | SEC 申报 ↗ |
| 2025-06-12 | Reynolds Cameron John | 买入 (P) | Common Stock | 12,500 | USD 0.59 | USD 7,375 | SEC 申报 ↗ |
| 2025-06-03 | Innes Guy Archibald | 买入 (P) | Common Stock | 20,000 | USD 0.54 | USD 10,800 | SEC 申报 ↗ |
| 2025-05-19 | Reynolds Cameron John | 买入 (P) | Common Stock | 20,000 | USD 0.44 | USD 8,800 | SEC 申报 ↗ |
| 2025-05-19 | Micallef Jacob Vincent | 买入 (P) | Common Stock | 50,000 | USD 0.43 | USD 21,500 | SEC 申报 ↗ |
| 2025-03-26 | Reynolds Cameron John | 买入 (P) | Common Stock | 181,818 | USD 0.55 | USD 100,000 | SEC 申报 ↗ |
| 2025-03-26 | Innes Guy Archibald | 买入 (P) | Common Stock | 181,818 | USD 0.55 | USD 100,000 | SEC 申报 ↗ |
| 2024-12-09 | STILL TIMOTHY I | 买入 (P) | Common Stock | 87,382 | USD 0.57 | USD 49,808 | SEC 申报 ↗ |
| 2024-12-09 | Reynolds Cameron John | 买入 (P) | Common Stock | 139,811 | USD 0.57 | USD 79,692 | SEC 申报 ↗ |
Form 4 申报证据
45 transaction lines in the latest 365-day window; 431 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Michel Gaetan | 代扣税 (F) | Common Stock | 608 | USD 0.25 | USD 152 | SEC 申报 ↗ |
| 2026-09-28 | Forterre Gael | 代扣税 (F) | Common Stock | 284 | USD 0.25 | USD 71 | SEC 申报 ↗ |
| 2026-03-17 | Rootsaert Rodney Gerard | 代扣税 (F) | Common Stock | 3,948 | USD 0.19 | USD 750 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-28 | Michel Gaetan | 代扣税 (F) | Common Stock | 608 | USD 0.25 | USD 152 | SEC 申报 ↗ |
| 2026-09-28 | Forterre Gael | 代扣税 (F) | Common Stock | 284 | USD 0.25 | USD 71 | SEC 申报 ↗ |
| 2026-03-17 | Rootsaert Rodney Gerard | 代扣税 (F) | Common Stock | 3,948 | USD 0.19 | USD 750 | SEC 申报 ↗ |
| 2026-03-17 | Plummer Nicholas | 代扣税 (F) | Common Stock | 7,003 | USD 0.19 | USD 1,331 | SEC 申报 ↗ |
| 2026-03-17 | Micallef Jacob Vincent | 代扣税 (F) | Common Stock | 5,310 | USD 0.19 | USD 1,009 | SEC 申报 ↗ |
| 2026-03-17 | Forterre Gael | 代扣税 (F) | Common Stock | 5,251 | USD 0.19 | USD 998 | SEC 申报 ↗ |
| 2026-03-01 | Rootsaert Rodney Gerard | 代扣税 (F) | Common Stock | 3,321 | USD 0.21 | USD 697 | SEC 申报 ↗ |
| 2026-03-01 | Plummer Nicholas | 代扣税 (F) | Common Stock | 5,867 | USD 0.21 | USD 1,232 | SEC 申报 ↗ |
| 2026-03-01 | Forterre Gael | 代扣税 (F) | Common Stock | 2,283 | USD 0.21 | USD 479 | SEC 申报 ↗ |
| 2026-02-26 | Rubin Ethel | 奖励／授予 (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Rootsaert Rodney Gerard | 奖励／授予 (A) | Common Stock | 119,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Reynolds Cameron John | 奖励／授予 (A) | Common Stock | 486,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Plummer Nicholas | 奖励／授予 (A) | Common Stock | 187,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Nguyen Kim | 奖励／授予 (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Micallef Jacob Vincent | 奖励／授予 (A) | Common Stock | 149,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Kway Jasmine | 奖励／授予 (A) | Common Stock | 173,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Innes Guy Archibald | 奖励／授予 (A) | Common Stock | 178,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Hughes Terig | 奖励／授予 (A) | Common Stock | 202,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Forterre Gael | 奖励／授予 (A) | Common Stock | 149,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-26 | Batchelor Ann-Louise | 奖励／授予 (A) | Common Stock | 142,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-01 | Rootsaert Rodney Gerard | 代扣税 (F) | Common Stock | 3,196 | USD 0.29 | USD 927 | SEC 申报 ↗ |
| 2026-02-01 | Plummer Nicholas | 代扣税 (F) | Common Stock | 5,647 | USD 0.29 | USD 1,638 | SEC 申报 ↗ |
| 2026-02-01 | Forterre Gael | 代扣税 (F) | Common Stock | 2,010 | USD 0.29 | USD 583 | SEC 申报 ↗ |
| 2026-01-22 | STILL TIMOTHY I | 奖励／授予 (A) | Common Stock | 90,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Rubin Ethel | 奖励／授予 (A) | Common Stock | 12,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Rootsaert Rodney Gerard | 奖励／授予 (A) | Common Stock | 28,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Reynolds Cameron John | 奖励／授予 (A) | Common Stock | 74,700 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Plummer Nicholas | 奖励／授予 (A) | Common Stock | 44,700 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Nguyen Kim | 奖励／授予 (A) | Common Stock | 12,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-22 | Micallef Jacob Vincent | 奖励／授予 (A) | Common Stock | 35,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VNRX |
| CIK | 0000093314 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 431 transaction lines from 2020-01-12 to 2026-09-28 61 P purchase lines · 12 S sale lines · 358 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.